SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
IBRX

ImmunityBio, Inc. (IBRX)

NASDAQ: IBRX · Real-Time Price · USD
Healthcare · Biotechnology
7.84-0.38 (-4.56%)
 
Market cap
$8.31B
Analyst consensus
Insider Score
––Not scored
IBRX Insider Score

Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.

IBRX analyst forecast

IBRX analyst consensus

Moderate Buy2 ratings
Buy 2 Hold 0 Sell 0

Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.

IBRX 12-month price target

No published price targets in the last 12 months.

Best analysts covering IBRX

  • HC Wainwright & Co.100%success rate · 6 calls
  • Piper Sandler100%success rate · 1 call
  • D. Boral Capital82%success rate · 28 calls
  • Jefferies0%success rate · 1 call

Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.

IBRX analyst ratings

FirmPrice targetAction
—JefferiesBuy——Reiterated2026-10-15
—HC Wainwright & Co.Buy——Reiterated2026-10-15
—HC Wainwright & Co.Buy——Reiterated2026-06-02
—BTIGBuy——Reiterated2026-05-21
—HC Wainwright & Co.Buy——Reiterated2026-05-20
—D. Boral CapitalBuy——Reiterated2026-05-05
—D. Boral CapitalBuy——Reiterated2026-04-21
—D. Boral CapitalBuy——Reiterated2026-04-08
—D. Boral CapitalBuy——Reiterated2026-03-26
—D. Boral CapitalBuy——Reiterated2026-03-23
—D. Boral CapitalBuy——Reiterated2026-03-17
—D. Boral CapitalBuy——Reiterated2026-03-09
—Piper SandlerOverweight——Reiterated2026-03-04
—D. Boral CapitalBuy——Reiterated2026-02-23
—HC Wainwright & Co.Buy——Reiterated2026-02-23
—D. Boral CapitalBuy——Reiterated2026-02-19
—D. Boral CapitalBuy——Reiterated2026-02-17
—HC Wainwright & Co.Buy——Reiterated2026-01-26
—BTIGBuy——Reiterated2026-01-23
—D. Boral CapitalBuy——Reiterated2026-01-23
—D. Boral CapitalBuy——Reiterated2026-01-20
—Piper SandlerOverweight——Reiterated2026-01-20
—D. Boral CapitalBuy——Reiterated2026-01-16
—D. Boral CapitalBuy——Reiterated2026-01-13
—D. Boral CapitalBuy——Reiterated2025-12-16
—D. Boral CapitalBuy——Reiterated2025-12-12
—JefferiesBuy——Reiterated2025-12-12
—D. Boral CapitalBuy——Reiterated2025-12-11
—D. Boral CapitalBuy——Reiterated2025-11-13
—D. Boral CapitalBuy——Reiterated2025-11-05
—HC Wainwright & Co.Buy——Reiterated2025-09-10
—D. Boral CapitalBuy——Reiterated2025-09-08
—D. Boral CapitalBuy——Reiterated2025-08-26
—D. Boral CapitalBuy——Reiterated2025-08-19
—D. Boral CapitalBuy——Reiterated2025-08-14
—D. Boral CapitalBuy——Reiterated2025-08-05
—D. Boral CapitalBuy——Reiterated2025-07-25
—D. Boral CapitalBuy——Reiterated2025-07-08
—HC Wainwright & Co.Buy——Reiterated2025-06-04
—D. Boral CapitalBuy——Reiterated2025-06-03
—D. Boral CapitalBuy——Reiterated2025-05-28
—Piper SandlerOverweight——Upgraded2025-05-20
—HC Wainwright & Co.Buy——Reiterated2025-05-12
—D. Boral CapitalBuy——Reiterated2025-05-12
—HC Wainwright & Co.Buy——Reiterated2025-04-28
—D. Boral CapitalBuy——Reiterated2025-04-28
—D. Boral CapitalBuy——Reiterated2025-04-23
—HC Wainwright & Co.Buy——Reiterated2025-04-16
—D. Boral CapitalBuy——Reiterated2025-04-15
—D. Boral CapitalBuy——Reiterated2025-04-09
—D. Boral CapitalBuy——Reiterated2025-03-31
—HC Wainwright & Co.Buy——Reiterated2025-03-13
—D. Boral CapitalBuy——Reiterated2025-03-13
—D. Boral CapitalBuy——Reiterated2025-03-03
—D. Boral CapitalBuy——Reiterated2025-02-28
—D. Boral CapitalBuy——Reiterated2025-02-19
—D. Boral CapitalBuy——Reiterated2025-02-14
—D. Boral CapitalBuy——Reiterated2025-01-30
—D. Boral CapitalBuy——Reiterated2025-01-27
—D. Boral CapitalBuy——Reiterated2025-01-16

IBRX earnings vs. estimates

QuarterEPS est.EPS actualRevenue est.Revenue actual
2026-02-23-0.08-0.06$38.4M$38.3M
2026-05-07-0.08-0.62$43.1M$44.2M
2026-08-04-0.08-0.22$49.7M$51.2M
2026-11-03-0.070.00$59.2M$0
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.